CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,192,759
- in 6 filings, $5.2M under 10b5-1 plans
Net −$5,192,759. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise · Restricted Stock Units | −16,975 | 16,975 | ||
| 2026-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise · Restricted Stock Units | −23,121 | 46,243 | ||
| 2026-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise · Restricted Stock Units | −14,878 | 44,634 | ||
| 2026-03-15 | Neervannan Seshadri Chief Operating Officer | Option exercise | +26,287 | 97,104 | ||
| 2026-03-15 | Neervannan Seshadri Chief Operating Officer | Option exercise · Restricted Stock Units | −5,097 | 0 | ||
| 2026-03-15 | Neervannan Seshadri Chief Operating Officer | Option exercise · Restricted Stock Units | −8,148 | 8,148 | ||
| 2026-03-15 | Neervannan Seshadri Chief Operating Officer | Option exercise · Restricted Stock Units | −8,020 | 16,040 | ||
| 2026-03-15 | Neervannan Seshadri Chief Operating Officer | Option exercise · Restricted Stock Units | −5,022 | 15,067 | ||
| 2026-03-15 | Mottiwala Aziz Chief Commercial Officer | Option exercise | +26,482 | 74,536 | ||
| 2026-03-15 | Mottiwala Aziz Chief Commercial Officer | Option exercise · Restricted Stock Units | −4,790 | 0 | ||
| 2026-03-15 | Mottiwala Aziz Chief Commercial Officer | Option exercise · Restricted Stock Units | −8,148 | 8,148 | ||
| 2026-03-15 | Mottiwala Aziz Chief Commercial Officer | Option exercise · Restricted Stock Units | −8,020 | 16,040 | ||
| 2026-03-15 | Mottiwala Aziz Chief Commercial Officer | Option exercise · Restricted Stock Units | −5,524 | 16,574 | ||
| 2026-03-15 | Farrow Jeffrey S See Remarks | Option exercise | +13,042 | 49,746 | ||
| 2026-03-15 | Farrow Jeffrey S See Remarks | Option exercise · Restricted Stock Units | −8,020 | 16,040 | ||
| 2026-03-15 | Farrow Jeffrey S See Remarks | Option exercise · Restricted Stock Units | −5,022 | 15,067 | ||
| 2026-03-05 | Lin Elizabeth Yeu Chief Medical Officer | Grant or award · Stock Option (right to buy) | +27,310 | 27,310 | ||
| 2026-03-05 | Lin Elizabeth Yeu Chief Medical Officer | Grant or award · Restricted Stock Units | +17,161 | 17,161 | ||
| 2026-03-05 | Wahl Bryan General Counsel | Grant or award · Stock Option (right to buy) | +27,310 | 27,310 | ||
| 2026-03-05 | Wahl Bryan General Counsel | Grant or award · Restricted Stock Units | +17,161 | 17,161 |
Page 6 of 13 · 257 trades